Home Diagnostics, developer of blood glucose monitoring systems and disposable supplies for diabetics, announced the terms for its IPO on Monday. The Fort Lauderdale, FL based company is expected to offer 6.6 million shares at a range of $14-$16. The proposed market cap for the deal is $299 million. Joint book runners JP Morgan and Piper Jaffray have yet to announce timing for the deal.
